From the Guidelines
The best and fastest way to reverse the effects of warfarin is to administer intravenous Vitamin K (phytonadione) along with Prothrombin Complex Concentrate (PCC), with PCC given at a dose of 25-50 units/kg based on INR level, as it can normalize clotting within minutes, as recommended by the 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants 1. This approach is supported by the most recent and highest quality study, which suggests that PCC is preferred over fresh frozen plasma (FFP) for warfarin reversal in emergency situations due to its faster onset of action, minimal risk of fluid overload, and lower risk of transmitting infection 1. The use of PCC has been shown to result in a more rapid INR normalization, reduced requirement for packed red blood cells, and decreased mortality compared to FFP 1. Additionally, the administration of Vitamin K helps to replete stores of clotting factors II, VII, IX, and X, thereby increasing the speed of reversal and reducing the INR over 4-6 hours for IV infusion and up to 24 hours for oral administration 1. The specific reversal approach should be tailored to the clinical urgency, with consideration of the patient's bleeding risk and need for future anticoagulation. Some key points to consider include:
- PCC is dosed based on INR level and body weight, with a recommended dose of 25 U/kg for INR 2-4,35 U/kg for INR 4-6, and 50 U/kg for INR >6 1.
- Vitamin K should be administered at a dose of 5-10 mg intravenously, with a slow infusion over 20-30 minutes to avoid anaphylactoid reactions 1.
- FFP is an alternative when PCC is unavailable, but it requires larger volumes and takes longer to administer 1.
- The reversal strategy works because warfarin inhibits vitamin K-dependent clotting factors, and administering Vitamin K restores the body's ability to produce these factors, while PCC directly replaces the depleted clotting factors 1.
From the FDA Drug Label
OVERDOSAGE ... Excessive anticoagulation, with or without bleeding, may be controlled by discontinuing warfarin sodium tablets therapy and if necessary, by administration of oral or parenteral vitamin K1. ... In emergency situations of severe hemorrhage, clotting factors can be returned to normal by administering 200 to 500 mL of fresh whole blood or fresh frozen plasma, or by giving commercial Factor IX complex
- The best and fastest way to reverse the effects of warfarin is by discontinuing warfarin therapy and administering parenteral vitamin K1.
- In emergency situations of severe hemorrhage, clotting factors can be returned to normal by administering fresh whole blood, fresh frozen plasma, or commercial Factor IX complex.
- The dosage of parenteral vitamin K1 is 5 to 25 mg (rarely up to 50 mg) for minor bleeding that progresses to major bleeding 2.
From the Research
Warfarin Reversal Strategies
The best and fastest way to reverse the effects of warfarin involves the use of prothrombin complex concentrates (PCC) or fresh frozen plasma (FFP) in combination with vitamin K1 3, 4, 5.
- PCC is preferred over FFP for immediate reversal due to its faster INR correction and lower risk of volume overload 4.
- Four-factor PCC (4FPCC) is recommended for urgent warfarin reversal, replacing three-factor PCC (3FPCC), as it provides all the necessary vitamin K-dependent clotting factors 5.
- Activated PCC (aPCC) has also been shown to be effective in reversing warfarin in patients with traumatic intracranial hemorrhage, with a faster time to INR reversal compared to FFP 6.
Comparison of Reversal Agents
Studies have compared the efficacy and safety of different reversal agents, including:
- PCC vs FFP: PCC is associated with a significant reduction in all-cause mortality, faster INR reduction, and less volume overload compared to FFP 4.
- 4FPCC vs FFP: 4FPCC is recommended for urgent warfarin reversal, as it provides all the necessary vitamin K-dependent clotting factors and obviates the need for co-administration of FFP 5.
- aPCC vs FFP: aPCC is effective in reversing warfarin in patients with traumatic intracranial hemorrhage, with a faster time to INR reversal compared to FFP 6.
Thromboembolic Risk
The thromboembolic risk associated with different reversal agents has also been studied: